The prognostic value of Notch pathway overexpression is strengthened by the evidence that abrogation of Notch3, Notch4, and Jagged2 signaling increases AML cell chemosensitivity in vitro [17]. This evidence concerns the gene JAG2 and acute myeloid leukemia.